Skip to main content
Equibles

Creative Planning

Position in TGTX — Tg Therapeutics, Inc.

CIK 1540235 OVERLAND PARK, KS
Back to TGTX Full portfolio

Position in TGTX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$6,109,602
+$3,986,977 QoQ
Shares Held
111,205
+74.0% QoQ
Ownership
0.073%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#87
of 426 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority Sole 1% Shared 0% None 99%

Common Shares in TGTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Creative Planning holds $457,365,908 across 219 Biotechnology names. TGTX ranks #23 (1.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 127,672 $63,418,511
2 REGN
Regeneron Pharmaceuticals, Inc.
 36,949 $23,039,178
3 EXEL
Exelixis, Inc.
 270,292 $14,706,586
4 INCY
Incyte Corp
 110,664 $12,544,870
5 CYTK
Cytokinetics Inc
 141,939 $12,091,783
6 RVMD
Revolution Medicines, Inc.
 64,120 $12,008,393
7 ARGX
Argenx SE
 12,744 $11,823,500
8 BMRN
Biomarin Pharmaceutical Inc
 153,161 $8,763,872

All Filings in TGTX

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,109,602 111,205
2026-03-31 $2,122,625 63,896
2025-12-31 $1,874,721 62,889
2025-09-30 $2,756,626 76,308
2025-06-30 $2,906,300 80,753
2025-03-31 $3,481,156 88,287
2024-12-31 $1,771,685 58,860
2024-09-30 $1,305,910 55,832
2024-06-30 $833,264 46,839
2024-03-31 $528,744 34,763
2023-12-31 $491,988 28,805
2023-09-30 $214,216 25,624
2023-06-30 $673,114 27,098
2023-03-31 $388,047 25,801
2022-12-31 $293,738 24,830
2022-09-30 $148,284 25,048
2022-06-30 $105,744 24,881
2021-12-31 $1,538,164 80,956
2021-09-30 $873,267 26,240
2021-06-30 $780,842 20,130
2021-03-31 $544,708 11,301
2020-12-31 $491,641 9,451